Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice Copérnico
  • Google Académico
  • sherpa romeo
  • Abrir puerta J
  • Revista GenámicaBuscar
  • Claves Académicas
  • InvestigaciónBiblia
  • Infraestructura Nacional del Conocimiento de China (CNKI)
  • Acceso a la Investigación Global en Línea en Agricultura (AGORA)
  • Biblioteca de revistas electrónicas
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catálogo en línea SWB
  • Biblioteca Virtual de Biología (vifabio)
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • ICMJE
Comparte esta página

Abstracto

Laboratory to Bedside: Biotechnology's Place in Healthcare's Transformational Development Environment

Lianjie Miao

The current state of healthcare is shifting due to the fast developing field of biotechnology, which has the potential to revolutionize how illnesses are identified and treated. Healthcare biotechnology has been the topic of many great efforts, and our understanding of it has grown significantly. New biomedical paradigms are developing as a result of the most recent developments in genetics and molecular biology, igniting fresh research into brandnew solutions for human health and wellbeing. However, an exciting obstacle still exists in the practical translational development of revolutionary technological discoveries. Only a small number of biotech breakthroughs have led to brand-new, revolutionary treatments and technologies for healthcare. We shall describe the clinical translational development atmosphere for biotechnology in healthcare in this paper. Notable medical biotechnology achievements and translational promotions, including historical findings and novel perspectives are carefully covered. More groundbreaking biotech ideas are about to be translated into commercial products to bring about positive health gains, despite the fact that there are nevertheless numerous obstacles in the bench-to-bedside translational development process. This is being carried out with a tight multitude of collaboration among research institutes, healthcare providers, and industry partners.